10x Genomics, Inc. company logo
10x Genomics, Inc. logo

10x Genomics, Inc. (TXG) Cash From Financing

Annual CFF

$10.91M$2.76M-20.16%

Summary

Current Value
As of today, TXG annual cash from financing is $10.91M, down -20.16% on
Historical Performance
TXG annual cash from financing is down -69.08% over the past 3 years, and down -97.37% over the past 5 years
All-Time High Comparison
TXG annual cash from financing is currently -97.67% below its historical high of $468.91M set on
3-Year Low Comparison
TXG annual cash from financing is at its 3-year low
Sector Comparison
TXG annual cash from financing is higher than 54.83% of companies in Healthcare sector

Cash From Financing Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

TXG Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash From Financing$10.91M-20.2%-69.1%-97.4%-47.0%
Quarterly Cash From Financing$617.00K+295.5%-69.7%-99.9%
TTM Cash From Financing$9.08M-24.4%-54.0%-98.0%
Price$19.99+28.7%-47.1%-87.4%
Annual Cash From Operations$6.66M+143.8%+131.2%-80.8%+162.3%
Annual Cash From Investing-$32.63M-124.4%+69.4%+23.7%-768.8%
Annual Dividends Paid$0.000.0%0.0%0.0%0.0%
Annual Total Debt$82.61M-13.4%+0.8%+178.0%-51.1%
Shares Outstanding126.55M+3.5%+9.9%+16.6%

Cash From Financing Highs

TXG Annual Cash From Financing Highs Comparison
PeriodHighDateCurrent
3Y$15.82MN/A-31.0%
5Y$468.91MN/A-97.7%
All$468.91M-97.7%

Cash From Financing Lows

TXG Annual Cash From Financing Lows Comparison
PeriodLowDateCurrent
3Y$10.91Mat low
5Y$10.91Mat low
All$10.91Mat low

Cash From Financing History

YearValueChange
$10.91M-20.2%
$13.67M-13.6%
$15.82M-55.2%
$35.30M-92.5%
YearValueChange
$468.91M+13.1%
$414.59M+293.5%
$105.37M+411.9%
$20.58M-

FAQ

  • What is the current annual cash from financing of TXG?

    As of today, TXG annual cash from financing is $10.91M

  • What is 1-year change in TXG annual cash from financing?

    TXG annual cash from financing is down -20.16% year-over-year

  • What is 3-year change in TXG annual cash from financing?

    TXG annual cash from financing is down -69.08% over the past 3 years

  • How far is TXG annual cash from financing from its all-time high?

    TXG annual cash from financing is currently -97.67% below its historical high of $468.91M set on December 31, 2020

  • How does TXG annual cash from financing rank versus sector peers?

    TXG annual cash from financing is higher than 54.83% of companies in Healthcare sector

  • When is TXG next annual earnings release?

    The next annual earnings release for TXG is on

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

Data Sources & References

  1. TXG Official Website www.10xgenomics.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1770787/000162828025050332/0001628280-25-050332-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1770787/000177078725000013/0001770787-25-000013-index.htm
  4. TXG Profile on Yahoo Finance finance.yahoo.com/quote/TXG
  5. TXG Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/txg